Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Overview
3. Systemic consequences and co-morbidity
4. What is COPD?
5. What is a co-morbidity?
6. Comorbid diagnoses and symptoms in COPD
7. Co-morbidity in COPD (1)
8. More common than...
9. Some common comorbidities in COPD patients
10. Lung cancer, COPD and smoking
11. Clinical importance of assessing co-morbidity
12. Why co-morbidity is important
13. COPD affects co-morbidity
14. Co-morbidity affects COPD
15. Exacerbation susceptibility
16. GORD in COPD
17. COPD & co-morbidity: a reciprocal relationship
18. Mechanisms of co-morbidity in COPD
19. Co-morbidity in COPD (2)
20. COP(D) and ageing
21. Co-morbidity in COPD (3)
22. Mechanisms
23. Questions
24. Systemic inflammation and vascular risk
25. RA and vascular risk
26. COPD: systemic inflammation
27. Systemic and airway inflammation in COPD
28. Systemic inflammation at exacerbation of COPD
29. COPD and MI risk (1)
30. COPD and MI risk (2)
31. Management of co-morbidity in COPD
32. Principles
33. UK NICE guidance
34. GOLD: COPD and co-morbidities
35. Conclusion
36. Thank you

Topics Covered

• COPD is associated with multiple systemic co-morbidities including increased cardiovascular risk, osteoporosis, metabolic disturbance, and skeletal muscle dysfunction
• The importance of assessing co-morbidity in COPD
• The mechanisms of interaction between COPD and co-morbidities
• How to manage co-morbidity in a patient with COPD

Links

Series:

• Advances in Chronic Obstructive Pulmonary Disease (COPD)

Categories:

• Clinical Practice

Therapeutic Areas:

• Immunology & Inflammation
• Respiratory Diseases

Talk Citation

Publication History

• Published on August 1, 2012
• Archived on February 25, 2021

Financial Disclosures

• Dr. John Hurst has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.